BAY865321, HD 8mg, AMD - Ph 3
Research payments
$9,020,475
Through program year 2023, $9,020,475 in research payments was reported against BAY865321, HD 8mg, AMD - Ph 3, across 794 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $5,777,357 | 635 |
| 2022 | Research | $3,243,118 | 159 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Brown Houston, TX Named on 58 payments
- Mark Chiu Albuquerque, NM Named on 56 payments
- David Eichenbaum St Petersburg, FL Named on 42 payments
- Aaron Weinberg Elmhurst, IL Named on 38 payments
- Eric Suan Baltimore, MD Named on 30 payments
- Vrinda Hershberger Melbourne, FL Named on 25 payments
- James Dooner Austin, TX Named on 21 payments
- Scott McClintic Salem, OR Named on 20 payments
- Patrick Higgins Bloomfield, NJ Named on 19 payments
- Payam Amini Pasadena, CA Named on 18 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.